
ADVANCE-ID marked a significant milestone on 31 August 2026 with the official launch of its designation as a World Health Organization (WHO) Collaborating Centre for Clinical Trials, reinforcing its commitment to strengthening clinical research capacity and advancing infectious diseases research across the region.
Based at the National University of Singapore’s Saw Swee Hock School of Public Health, ADVANCE-ID is Singapore’s 13th WHO Collaborating Centre and the first in WHO’s Western Pacific Region dedicated to clinical trials.
The designation recognises ADVANCE-ID’s efforts to strengthen regional clinical trial networks, build research capacity, and foster international collaboration to generate high-quality evidence that informs clinical practice and public health policy.
The milestone also received coverage in Singapore’s leading newspapers, The Straits Times and Lianhe Zaobao, highlighting the importance of regional partnerships in addressing infectious diseases and emerging public health challenges.
As a WHO Collaborating Centre, ADVANCE-ID looks forward to working closely with WHO and its regional partners to advance clinical trial capabilities, strengthen research ecosystems, and improve health outcomes across Asia and beyond.
References / links
The Straits Times: https://ad-id.co/4ijgGjk
Lianhe Zaobao: https://ad-id.co/48dQtxQ
